Business Context and Reporting Period
This Form 8-K is filed by Xcyte Therapies, Inc. (not Bio Green Med Solution, Inc.) for the reporting period ending October 31, 2005. The filing addresses the termination of a material definitive agreement with General Electric Corporation (GE).
Key Financial Metrics
- Debt Repayment: $2,218,614 paid to GE to satisfy obligations under a Master Security Agreement dated May 1, 2000.
- Liquidity Impact: The company received a deposit return of $170,961 from GE upon payment of the obligations.
- Net Cash Outflow: Approximately $2,047,653 (calculated as payment minus deposit return).
- Revenue/Profit/Margins: The filing text does not provide a clear value for revenue, profit, cash flow, or margins.
Material Changes
The primary material change is the full prepayment of equipment financing obligations to GE. This action removes GE's security interest in the company's equipment, providing flexibility for a previously announced review of strategic alternatives.
Outlook, Risks, and Management Commentary
Management prepaid the obligations specifically to facilitate the review of strategic alternatives by clearing liens on equipment. There are no material relationships between Xcyte and GE other than the terminated agreement. The filing does not contain forward-looking guidance, risk factors, or discussion of unusual items beyond the debt settlement.
Investor Verification Checklist
- Verify the status of the "review of strategic alternatives" mentioned as the rationale for the prepayment.
- Confirm the total cash balance remaining after the $2.2 million outflow.
- Check for subsequent filings regarding the outcome of the strategic review.
- Ensure the $170,961 deposit return was actually received and recorded.